Citation Impact
Citing Papers
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
2013 StandoutScience
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Hepatitis C virus structural proteins do not prevent human dendritic cell maturation
2008
IL-10: The Master Regulator of Immunity to Infection
2008 Standout
Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
2012
Allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain site II: Structure-based design and synthesis of new templates
2010
Efficacy and Safety of Atazanavir-Based Highly Active Antiretroviral Therapy in Patients with Virologic Suppression Switched from a Stable, Boosted or Unboosted Protease Inhibitor Treatment Regimen: The SWAN Study (AI424-097) 48-Week Results
2007
Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection
2005
SEC14L2 enables pan-genotype HCV replication in cell culture
2015 StandoutNatureNobel
A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
2006
Hepatocellular carcinoma
2018 Standout
T cell exhaustion
2011 Standout
Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis
2013
Whole Genome Pyrosequencing of Rare Hepatitis C Virus Genotypes Enhances Subtype Classification and Identification of Naturally Occurring Drug Resistance Variants
2012
Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
2011 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Progress in the development of preventive and therapeutic vaccines for hepatitis C virus
2011
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic
2009
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
2013
Strategies for development of dengue virus inhibitors
2010
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Response to Hepatitis B Vaccine in HIV‐1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies
2005
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease†
2004
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor
2005
Association of tenofovir exposure with kidney disease risk in HIV infection
2012
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Management of the metabolic effects of HIV and HIV drugs
2011
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
2011
Use of therapeutic drug monitoring in HIV disease
2008
Liver enzyme elevation after lamivudine withdrawal in HIV–hepatitis B virus co‐infected patients: the Swiss HIV Cohort Study
2008
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
2016
Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus
2004
Impaired Function of Dendritic Cells Circulating in Patients Infected with Hepatitis C Virus Who Have Persistently Normal Alanine Aminotransferase Levels
2005
Update on hepatitis C virus resistance to direct-acting antiviral agents
2014
Systematic Review and Meta‐analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV‐Infected Patients
2010
Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C
2005 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection
2004
Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus†
2009
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults
2007
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
Monocyte‐derived dendritic cells from HCV‐infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)
2008
Engulfment of apoptotic cells expressing HCV proteins leads to differential chemokine expression and STAT signaling in human dendritic cells
2007
Hepatitis C Virus Entry
2007 StandoutNobel
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
2005
Plasmacytoid Dendritic Cells: In Search of their Niche in Immune Responses
2005
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
2012
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
Computational design of orthogonal nucleoside kinases
2010 StandoutNobel
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors
2004
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection
2004
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytes
2003
Innate Immune Responses to Hepatitis C Virus
2013 StandoutNobel
Kinetics of the Immune Response During Hbv and Hcv Infection
2003
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial
2013 Standout
Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus
2005
Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment
2003
Peginterferon alone or with ribavirin enhances HCV-specific CD4+ T-helper 1 responses in patients with chronic hepatitis C
2002
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Replication of hepatitis C virus
2007 StandoutNobel
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world
2011
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities
2005
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Utility of Humanized BLT Mice for Analysis of Dengue Virus Infection and Antiviral Drug Testing
2013 StandoutNobel
Selective Impairments in Dendritic Cell-Associated Function Distinguish Hepatitis C Virus and HIV Infection
2004
Twenty-Six Years of Anti-HIV Drug Discovery: Where Do We Stand and Where Do We Go?
2009
Antiviral Combination Therapy for Treatment of Chronic Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection
2008
Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses
2003
Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro
2012 StandoutNobel
Memory T-Cell-Mediated Immune Responses Specific to an Alternative Core Protein in Hepatitis C Virus Infection
2004
Chronic Hepatitis C Virus Infection Established and Maintained in Chimpanzees Independent of Dendritic Cell Impairment
2003
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes
2002
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies
2011
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Modulation of dendritic cell function by persistent viruses
2008
Meta‐analysis: oral anti‐viral agents in adults with decompensated hepatitis B virus cirrhosis
2012
Antiretroviral drugs and liver injury
2008
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
2015 Standout
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
2013
HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation
2004 StandoutNobel
Cell-Mediated Immunity and the Outcome of Hepatitis C Virus Infection
2004
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
TLR Ligand-Dependent Activation of Naive CD4 T Cells by Plasmacytoid Dendritic Cells Is Impaired in Hepatitis C Virus Infection
2007
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
2009
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Works of Pablo Labarga being referenced
Predictors of Kidney Tubular Dysfunction in HIV‐Infected Patients Treated with Tenofovir: A Pharmacogenetic Study
2009
Impact of antiretroviral therapy on the variability of the HCV NS5B polymerase in HIV/HCV co-infected patients
2011
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV‐Infected Patients
2007
Renal toxicity associated with tenofovir use
2010
Effectiveness and Safety of Simplification Therapy with Once-Daily Tenofovir, Lamivudine, and Efavirenz in HIV-1–Infected Patients with Undetectable Plasma Viral Load on HAART
2007
Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy
2006
Liver cirrhosis in HIV‐infected patients: prevalence, aetiology and clinical outcome
2007
Emerging drugs for hepatitis C
2008
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients
2014
Hepatitis C therapy with HCV NS5B polymerase inhibitors
2013
Predictors of severe hepatic steatosis using abdominal ultrasound in HIV‐infected patients
2008
Treatment of Chronic Hepatitis B or C in HIV‐Infected Patients with Dual Viral Hepatitis
2007
Directly acting antivirals against hepatitis C virus
2011
Survival of HIV-infected patients with compensated liver cirrhosis
2010
Treatment failure with new hepatitis C drugs
2012
Outbreak of Syphilis, but Not of Acute Hepatitis C, Among HIV-Infected Homosexual Men in Madrid
2007
New Drug Targets for Hepatitis C and Other Flaviviridae Viruses
2009
Liver stiffness predicts liver-related complications and mortality in HIV patients with chronic hepatitis C on antiretroviral therapy
2013
Predicted Effect of Direct Acting Antivirals in the Current HIV–HCV-Coinfected Population in Spain
2011
Influence of Liver Fibrosis Stage on Plasma Levels of Antiretroviral Drugs in HIV‐Infected Patients with Chronic Hepatitis C
2007
Simplification Therapy with Once-Daily Didanosine, Tenofovir and Efavirenz in HIV-1-Infected Adults with Viral Suppression Receiving a More Complex Antiretroviral Regimen: Final Results of the EFADITE Trial
2005
Sustained Virological Response following HCV Therapy is Associated with Non-Progression of Liver Fibrosis in HCV/HIV-Coinfected Patients
2006
Abnormal Priming of CD4+T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins
2002